piRNA-Based Constructs for Silencing Pathogen Transmission Genes
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Transposable elements (TEs) integrate into host genomes, disrupting normal transcription and translation, and existing piRNA pathways are not fully understood in organisms like Anopheles gambiae, limiting their potential in immunity and disease transmission control.
Innovation Solution
Development of piRNA-based constructs that form RNP complexes with Piwi or Aubergine proteins to down-regulate target gene expression by hybridizing with mRNA transcripts, using specific piRNA sequences to inhibit essential genes for pathogen transmission and infection.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If piRNA pathways are used to control transposable elements, then genome integrity is maintained, but the pathway is not fully understood in Anopheles gambiae, limiting its potential for immunity and disease transmission control
Solution Approach 1:
The patent introduces piRNA constructs into the Anopheles gambiae germline before pathogen infection occurs. These constructs are designed to express piRNAs that will later target and silence genes essential for pathogen transmission, effectively preparing the immune defense mechanism in advance rather than responding after infection occurs.
Solution Approach 2:
The patent uses Piwi or Aubergine proteins as intermediary carriers to deliver and activate the introduced piRNA sequences. These proteins facilitate the formation of RNP complexes that guide the piRNAs to their target mRNA transcripts, enabling the system to leverage existing cellular machinery while achieving new functional capabilities.
2Object-affected harmful factors
If piRNA constructs are introduced to silence target genes, then pathogen transmission is reduced, but the complexity of the genetic construct increases
Solution Approach 1:
The patent divides the genetic construct into distinct functional segments: a promoter region, the piRNA sequence encoding region, and optional polyadenylation signals. This segmentation allows for modular design and independent optimization of each component while simplifying the overall construction process and facilitating standardized production.
Solution Approach 2:
The patent utilizes naturally occurring piRNA sequences from the Anopheles gambiae genome as templates for the introduced constructs. By copying and adapting existing piRNA sequences rather than creating entirely new ones, the patent reduces the complexity of sequence design while maintaining effectiveness in silencing target genes.
3Productivity
If piRNAs hybridize with mRNA transcripts to cause down-regulation, then target gene expression is reduced, but the precision of sequence matching must be maintained
Solution Approach 1:
The patent introduces piRNA sequences with specific local characteristics - including 5' uracil residues and particular nucleotide compositions - that enhance their ability to bind Piwi/Aubergine proteins and form stable RNP complexes. These localized quality enhancements ensure effective target recognition and silencing while maintaining overall sequence accuracy.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The constructs effectively silence genes critical for pathogen transmission, reducing disease spread in insect hosts like Anopheles gambiae and potentially protecting against pathogens such as Plasmodium falciparum.
Implementation Method 1
the one or more piRNAs comprise a piRNA nucleotide sequence that hybridizes to at least a portion of a mRNA transcript of the target gene
Data Source
AI summary
This disclosure is based, in part, on the unexpected discovery that a piRNA-based construct is able to silence genes that are essential for transmission and/or infection of pathogens. The disclosed constructs and methods of use thereof capitalize on the role piRNAs play in transcriptional silencing and general immunity and enable development of transgenic approaches to inhibit transmission of human and crop diseases.